Increasing the world-wide capacity for manufacturing influenza vaccines is critical for appropriate preparedness.
IVAC, a Vietnam vaccine manufacturer, has developed a split, trivalent seasonal vaccine, that has proven to be safe and immunogenic in this study.
The immunogenicity of the vaccine is comparable to that of similar vaccines, and thus warrants further development.